BOSTON — Annual exams with topography are key to identifying progression in patients with keratoconus regardless of whether they have undergone cross-linking, according to a speaker here.
At Cornea Day at the American Society of Cataract and Refractive Surgery meeting, William B. Trattler, MD, said that cross-linking is effective at stopping keratoconus progression, but there is still a risk for continued progression in about 2% to 4% of patients.
“There’s still a chance they can progress even with treatments,” he said. “That’s important to understand. They